Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial | Nature Medicine
MAD Cohorts 1 to 4: Participants receiving ECC5004 for Type 2 Diabetes Clinical Trial 2024 | Power
Statistical Analysis Plan (SAP)
EX-99.1
Quantitative Decision Making (QDM) in Phase I/II studies - ppt download
Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection | British Journal of Cancer
On Biostatistics and Clinical Trials: SAD and MAD: Single Ascending Dose and Multiple Ascending Dose first-in-human studies
S-1/A
Clinical Considerations for First-in-Human (FIH) and Early Phase Clinical Trials | Simbec-Orion
A Flow-chart of the single-ascending-dose (SAD) and... | Download Scientific Diagram
Adaptive and Innovative Study Designs to Accelerate Drug Development from First-In-Human to First-In-Patient
Study design. Subjects in SAD cohort 4, part 2, were dosed in the fed... | Download Scientific Diagram
imvt-ex992_73.pptx.htm
Frontiers | Molecular Signatures of Response to Mecasermin in Children With Rett Syndrome
Regulus Therapeutics Advances to Cohort 3 of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Illustrative 'accelerated' development 'go/no-go' plan of an add-on... | Download Scientific Diagram
On Biostatistics and Clinical Trials: November 2017
Types of Study in Early Clinical Development - EUPATI Toolbox
CR Tidbit – SAD MAD Studies | AuroBlog | Clinical Research Blog | Aurous HealthCare CRO, India
SEC Filing | Alkermes plc
EX-99.1
First in human dose - clinical trial designs.pptx
